In a 25-year career at Harvard Medical School and Boston’s Beth Israel and Brigham & Women’s hospitals, Baim helped establish interventional cardiology, creating and leading training programs for medical students in the discipline. He edited the standard medical textbook for angioplasty and other cardiac catheterization procedures.
Baim joined Boston Scientific in 2006, after a six-year tenure at the Brigham. He joined Beth Israel in 1981, after earning a medical degree at Yale University and studying cardiology and internal medicine at Stanford University.
BSX CEO Ray Elliot, in a statement to employees, called Baim an interventional cardiology “pioneer,” according to The Associated Press. A company spokesman had no comment for the news service on who might succeed Baim as CMO.